Correlation Between Apellis Pharmaceuticals and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Novo Nordisk AS, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Novo Nordisk.
Diversification Opportunities for Apellis Pharmaceuticals and Novo Nordisk
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apellis and Novo is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Novo Nordisk go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Novo Nordisk
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 2.17 times more return on investment than Novo Nordisk. However, Apellis Pharmaceuticals is 2.17 times more volatile than Novo Nordisk AS. It trades about 0.24 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.14 per unit of risk. If you would invest 2,771 in Apellis Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 643.00 from holding Apellis Pharmaceuticals or generate 23.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Novo Nordisk AS
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Novo Nordisk AS |
Apellis Pharmaceuticals and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Novo Nordisk
The main advantage of trading using opposite Apellis Pharmaceuticals and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Apellis Pharmaceuticals vs. Cue Biopharma | Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |